title: Serum CA 125 levels and survival in advanced ovarian cancer.
abstract: We made a retrospective analysis of 85 patients with elevated serum CA 125 after surgery for ovarian cancer. Absolute CA 125 serum levels were a poor guide to prognosis. However, the ratio between the serum CA 125 after the first, second, or third course of treatment and the postoperative value was an excellent guide to prognosis. These were also independent and stable in the Cox Regression analysis.
authors.affiliation: Department of Gynaecologic Oncology and Radiotherapy, Justus-Liebig-University of Giessen, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Münstedt
authors.forename: M
authors.initials: M
authors.lastname: Krisch
authors.forename: S
authors.initials: S
authors.lastname: Sachsse
authors.forename: H
authors.initials: H
authors.lastname: Vahrson
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018394:CA-125 Antigen / Q000097:blood*; D005260:Female; D006207:Half-Life; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood / Q000401:mortality* / Q000473:pathology; D011379:Prognosis; D012044:Regression Analysis; D012189:Retrospective Studies; D016019:Survival Analysis
chemical_list: D018394:CA-125 Antigen